Martin Duddy

6.0k citations

40 papers · 2.2k indexed · 1 hit paper · h-index 21

Impact in

Pathology and Forensic Medicine top 1%
- Multiple Sclerosis Research Studies
Immunology top 2%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation

Papers in

Pathology and Forensic Medicine 27
- Multiple Sclerosis Research Studies 27
Neurology 16
- Peripheral Neuropathies and Disorders 12

Co-authors: Amit Bar‐Or Andrea Alter Harry Atkins Masaaki Niino Ho Jin Kim Mark S. Freedman Jack P. Antel Mark R. Baker
Journals: The Journal of Immunology (5 papers)Multiple Sclerosis and Related Disorders (3 papers)Multiple Sclerosis Journal (3 papers)Journal of Neurology Neurosurgery & Psychiatry (2 papers)Journal of Neurology (2 papers)
Partner nations: United Kingdom Canada Germany

In The Last Decade

Martin Duddy

40 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis 2007 · 508 citations

Peers

Countries citing papers authored by Martin Duddy

Since Specialization

Citations

This map shows the geographic impact of Martin Duddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Duddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Duddy more than expected).

Fields of papers citing papers by Martin Duddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Duddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Duddy. The network helps show where Martin Duddy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martin Duddy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Duddy Line = papers co-authored together Martin Duddy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Transition to secondary progressive multiple sclerosis: The consequences for patients and healthcare systems, a healthcare professional survey Health Science Reports ·V. N. Zamoshnikov, 内山精也, 茅野晋平, Ebtihal Alharbi, Martin Duddy	2022	9
2	Delivering an advice and guidance service in neurology Practical Neurology ·Kirstie N. Anderson, Sergio A. Silverio, Martin Duddy, Paul G. McKean, James Miller	2022	2
3	Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK Journal of Medical Economics ·茅野晋平, 内山精也, Lu'lu' Ulkhofiyatun Nida, Kapil Gudala, Martin Duddy, Ebtihal Alharbi	2022	7
4	COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies Multiple Sclerosis and Related Disorders ·Afagh Garjani, Rod Middleton, Rachael Hunter, Amrei Bauseler, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen Pearson, David Rog, Emma Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou	2021	36
5	Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom Multiple Sclerosis and Related Disorders ·Martin Duddy, A. S. Nelyubina, Afnan Hassan Abdullah Al-Samen, Maria Angelica Martinez Covarrubias	2021	2
6	Neurostructural and Neurophysiological Correlates of Multiple Sclerosis Physical Fatigue: Systematic Review and Meta-Analysis of Cross-Sectional Studies Neuropsychology Review ·Mónica García Diéguez, Stuart Goodall, Niamh Kennedy, Helen Dawes, Allan Clark, Valerie M. Pomeroy, Martin Duddy, Mark R. Baker, John Saxton	2021	14
7	COVID-19 in people with MS: a large community-based study of the UK MS register Multiple Sclerosis Journal ·Alireza Garjani, Nikos Evangelou, Rajiv Nair, Robert P. Hunter, Amrei Bauseler, Mchael McCarthy, Eckart E. Goette, Martin Duddy, Valéria Pacheco, Susan Hughes, Owen Pearson, Laura E. Middleton, David Rog, Emma Tallantyre, Rod Middleton, Rebecca Nicholas	2020	1
8	Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme Journal of Neurology Neurosurgery & Psychiatry ·Jacqueline Palace, Martin Duddy, Michael Lawton, Thomas Bregenzer, Feng Zhu, Mike Boggild, Soon Chan Um, Neil P. Robertson, Joël Oger, Helen Tremlett, Kate Tilling, Yoav Ben‐Shlomo, Richard Lilford, Charles Dobson	2018	25
9	The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction Patient Preference and Adherence ·Mar Tintoré, Adrienne O'Shea, Kathleen Costello, Martin Duddy, David Jones, Nancy Law, Gilmore O’Neill, Antonio Uccelli, Robert Weissert, Sibyl Wray	2016	61
10	UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model BMJ Open ·Jacqueline Palace, Thomas Bregenzer, Helen Tremlett, Joël Oger, Kim Lee Hughes, Mike Boggild, Martin Duddy, Charles Dobson	2014	71
11	The UK patient experience of relapse in Multiple Sclerosis treated with first disease modifying therapies Multiple Sclerosis and Related Disorders ·Martin Duddy, Martin Lee, Owen Pearson, Esmaeil Nikfekr, Abhijit Chaudhuri, Mohamed FARHOUD, Maria Katarinae Kovacova, 崇人下田	2014	24
12	Modelling natural history for the UK multiple sclerosis risk-sharing scheme Multiple Sclerosis Journal ·Ginanjar Rizki Husada, Thomas Bregenzer, Helen Tremlett, Martin Duddy, M. Boggild, Feng Zhu, Joël Oger, Maxim Lipaev	2013	3
13	The Evolving Role of the Multiple Sclerosis Nurse - Implications of Future Management Directions European Neurological Review ·Alexander Valdez Disla, Virgil Grigore, Martin Duddy, (unknown), (unknown)	2012	1
14	Managing MS in a changing treatment landscape Journal of Neurology ·Martin Duddy, Aiden Haghikia, Eleonora Cocco, Christian Eggers, Jelena Drulović, Olga Carmona, Hélène Zéphir, Ralf Gold	2011	24
15	B-cell subsets: cellular interactions and relevance in multiple sclerosis Expert Review of Clinical Immunology ·Claudia J. Calder, Martin Duddy, Amit Bar‐Or	2006	1
16	Type 2 Monocyte and Microglia Differentiation Mediated by Glatiramer Acetate Therapy in Patients with Multiple Sclerosis The Journal of Immunology ·Jung Bin Kim, Igal Ifergan, Jack P. Antel, Rosanne Séguin, Martin Duddy, Yves Lapierre, Farzaneh Jalili, Amit Bar‐Or	2004	163
17	Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt–Jakob disease Journal of Infection ·N. V. Todd, Jason D. Morrow, Katsumi Doh‐ura, Stephen Dealler, A. Vázquez Barro, P. Farling, Martin Duddy, N. G. Rainov	2004	60
18	Determinants of Human B Cell Migration Across Brain Endothelial Cells The Journal of Immunology ·Andrea Alter, Martin Duddy, Pardis Basiri, Katarzyna Biernacki, Alexandre Prat, Jack P. Antel, V. Wee Yong, Robert K. Nuttall, Caroline J. Pennington, Dylan R. Edwards, Amit Bar‐Or	2003	159
19	Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State The Journal of Immunology ·Amit Bar‐Or, Enedina Maria Lobato de Oliveira, David E. Anderson, Lisa A. Donovan, Martin Duddy, Kevin C. O’Connor, David A. Hafler	2001	104
20	Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosis Journal of Neuroimmunology ·Martin Duddy, Mervyn Armstrong, A. D. Crockard, Stanley Hawkins	1999	27

About Martin Duddy

Martin Duddy is a scholar working on Pathology and Forensic Medicine, Neurology, Rheumatology, Immunology and Hematology, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (27 papers), Peripheral Neuropathies and Disorders (12 papers), Immunotherapy and Immune Responses (7 papers), Polyomavirus and related diseases (5 papers), T-cell and B-cell Immunology (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Immunology (1.0k citations), Neurology (489 citations), Neurology (250 citations) and Rheumatology (315 citations). Martin Duddy has collaborated with scholars based in United Kingdom, Canada and Germany. Frequent co-authors include Amit Bar‐Or, Andrea Alter, Harry Atkins, Masaaki Niino, Ho Jin Kim, Mark S. Freedman, Jack P. Antel, Mark R. Baker, Mervyn Armstrong and Jung Bin Kim. Their work appears in journals such as The Journal of Immunology, Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact